Literature DB >> 3928679

Risk of group A meningococcal disease: bacterial interference and cross-reactive bacteria among mucosal flora.

G A Filice, P S Hayes, G W Counts, J M Griffiss, D W Fraser.   

Abstract

During outbreaks of group A meningococcal disease in Seattle, Wash., and Portland, Oreg., we studied the mucosal flora of the affected population and comparison groups to identify possible determinants of susceptibility and resistance to disease. Antimeningococcal immunoglobulin A can block the bactericidal activity of specific antibodies of other classes and has been associated with susceptibility in adults. We used immunoprecipitation and fluorescent-antibody techniques to detect mucosal microorganisms cross-reactive with group A meningococci that might have stimulated such antibodies. Cross-reactive strains of Bacillus pumilus and Streptococcus faecalis were found. Bacterial interference on mucosal surfaces has been shown to reduce susceptibility to other pathogens. With an agar overlay technique, we sought nasopharyngeal microorganisms that inhibited the growth of group A meningococci. Forty-five percent of subjects carried inhibitory strains representing at least nine different species. Inhibitory strains were less common (32%) in residents from "skid row" areas (see D.J. Bogue, Skid Row in American Cities, University of Chicago Press, for a comprehensive definition of these areas) than in a comparison group that did not experience meningococcal disease (61%), suggesting that their presence may be associated with resistance to acquisition of meningococci or to meningococcal disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928679      PMCID: PMC268349          DOI: 10.1128/jcm.22.2.152-156.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Bacterial interference: its effect on nursery-acquired infection with Staphylococcus aureus. I. Preliminary observations on artificial colonzation of newborns.

Authors:  H R SHINEFIELD; J C RIBBLE; M BORIS; H F EICHENWALD
Journal:  Am J Dis Child       Date:  1963-06

2.  Bacterial antigens cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  M W Bradshaw; R Schneerson; J C Parke; J B Robbins
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

3.  Serum immunoglobulin concentrations in patients with alcoholic liver disease.

Authors:  I D Wilson; G Onstad; R C Williams
Journal:  Gastroenterology       Date:  1969-07       Impact factor: 22.682

4.  Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus.

Authors:  C C Crowe; W E Sanders; S Longley
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

5.  Bacterial interference. I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci by viridans streptococci.

Authors:  E Sanders
Journal:  J Infect Dis       Date:  1969-12       Impact factor: 5.226

6.  Inhibitors of leukocyte chemotaxis in alcoholic liver disease.

Authors:  D E Van Epps; R G Strickland; R C Williams
Journal:  Am J Med       Date:  1975-08       Impact factor: 4.965

7.  The influence of bacteriocins on resistance to infection by gram-negative bacteria. II. Colicin action, transfer of colicinogeny, and transfer of antibiotic resistance in urinary infections.

Authors:  A I Braude; J S Siemienski
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

8.  Stimulation by alcohols of cyclic AMP metabolism in human leukocytes. Possible role of cyclic AMP in the anti-inflammatory effects of ethanol.

Authors:  J P Atkinson; T J Sullivan; J P Kelly; C W Parker
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

9.  Polysaccharides of the genus Bacillus cross-reactive with the capsular polysaccharides of Diplococcus pneumoniae type 3, Haemophilus influenzae type b, and Neisseria meningitidis group A.

Authors:  R L Myerowitz; R E Gordon; J B Robbins
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

10.  Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide.

Authors:  W F Vann; T Y Liu; J B Robbins
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

View more
  4 in total

Review 1.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Antibiotic prescribing during an outbreak of meningococcal disease.

Authors:  J M Stuart; P M Robinson; K Cartwright; N D Noah
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

3.  Secular trends in invasive meningococcal disease, Massachusetts, 1988-2011: what happened to invasive disease?

Authors:  A H Peruski; P Kludt; R S Patel; A DeMaria
Journal:  Epidemiol Infect       Date:  2014-12       Impact factor: 4.434

4.  Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.

Authors:  Mariëtte B van Ravenhorst; Gerco den Hartog; Fiona R M van der Klis; Debbie M van Rooijen; Elisabeth A M Sanders; Guy A M Berbers
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.